Is the association of "cup-like" nuclei with mutation of the NPM1 gene in acute myeloid leukemia clinically useful?

Am J Clin Pathol

Department of Pathology, Hematopathology Section, the James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY 14642, USA.

Published: October 2010

Cup-like nuclear invaginations (NIs) in acute myeloid leukemia (AML) blasts have been associated with NPM1 mutations. Precision for enumeration of NI blasts has not been previously studied. Furthermore, the sensitivity and specificity for the morphologic prediction of NPM1 mutations have been variously reported. By using 66 AML specimens (17 with NPM1 mutations and 49 without), we found that interobserver reproducibility for enumeration of NI blasts was high (r = 0.98) and that identification of this feature was teachable (r = 0.96). No NPM1 mutation-negative case had greater than 7% NI blasts. The fraction of NI blasts was highly variable among 17 NPM1 mutation-positive cases, ranging from 0% to greater than 40%. These data indicate that an NI blast fraction of more than 10% is highly specific for NPM1 mutation-positive cases but with a sensitivity of about 30%. Therefore, although NI blasts can be reliably identified in routine smears and although they are a specific marker of NPM1 mutation-positive cases, the majority of NPM1 mutation-positive cases lack this distinctive finding.

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPULO8SLW0RKJLDOI Listing

Publication Analysis

Top Keywords

npm1 mutation-positive
16
mutation-positive cases
16
npm1 mutations
12
npm1
9
acute myeloid
8
myeloid leukemia
8
enumeration blasts
8
blasts
6
association "cup-like"
4
"cup-like" nuclei
4

Similar Publications

Acute myeloid leukemia (AML) is a highly heterogeneous hematological neoplasm, highlighting the need for new molecular markers to improve prognosis prediction and therapeutic strategies. While Rho guanine nucleotide exchange factor 5 (ARHGEF5) is known to be overexpressed in various cancers, its role in AML is not well understood. This study investigates the correlation between ARHGEF5 expression and AML using data from the Cancer Genome Atlas (TCGA).

View Article and Find Full Text PDF

To explore the clinical significance and prognosis of acute myeloid leukemia (AML) patients with WT1 mutations.In total, the clinical data of 269 adult patients with non-M3 AML were considered retrospectively. From these patients, 153 carried WT1 mutation whereas 116 were negative.

View Article and Find Full Text PDF

Mutation status of FLT3, NPM1, and CEBPA is used to classify the prognosis of acute myeloid leukemia, but its significance in patients with cytogenetically normal (CN) AML is unclear. We prospectively analyzed these genes in 295 patients with CN-AML and identified 76 (25.8%) FLT3-ITD, 113 (38.

View Article and Find Full Text PDF

Clinical characteristics and prognostic analysis of acute myeloid leukemia patients with PTPN11 mutations.

Hematology

December 2022

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, People's Republic of China.

Objectives: Little is known about the clinical impact of germline/somatic mutations of PTPN11 in acute leukemia. The aim of this study was to investigate the clinical characteristics and prognostic impact of PTPN11 mutations in patients with acute myeloid leukemia (AML).

Methods: Seventy-four patients with PTPN11 mutation-positive AML treated at our institution were enrolled in this study.

View Article and Find Full Text PDF
Article Synopsis
  • FMS-like tyrosine kinase 3 (FLT3) inhibitors like qiuzartinib significantly improve outcomes for patients with FLT3-internal tandem duplication (ITD)-positive acute myeloid leukemia (AML).
  • In the first case, a 47-year-old male showed no response to traditional treatment but achieved complete remission after receiving qiuzartinib.
  • The second case involved a 71-year-old female who also reached complete remission with qiuzartinib after showing partial response to another treatment, demonstrating the importance of recognizing cuplike blasts for accurate diagnosis and treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!